DCF — ST. MARGARETS HEALTH - SPRING VALLEY
Enterprise Value: $-172.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-172.2M
Enterprise Value
$-53.9M
PV of Cash Flows
$-118.3M
PV of Terminal Value
$-190.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $90.7M | $-11.0M | -12.0% | $-14.9M | $-13.5M |
| Year 2 | $93.4M | $-10.4M | -11.0% | $-14.4M | $-11.9M |
| Year 3 | $96.2M | $-9.8M | -10.0% | $-13.9M | $-10.4M |
| Year 4 | $99.1M | $-9.6M | -10.0% | $-13.8M | $-9.4M |
| Year 5 | $102.1M | $-9.6M | -9.0% | $-13.9M | $-8.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-172.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$88.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1267583367121141
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5